{"pmid":32405454,"pmcid":"PMC7219375","title":"Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran.","text":["Acute kidney injury in pregnant women following SARS-CoV-2 infection: A case report from Iran.","We reported a 33-year-old female case with novel coronavirus disease 2019 (COVID-19) accompanied by Acute tubular necrosis (ATN). She had a gestational age of 34 weeks. The patient referred to treatment clinic for COVID-19 in Imam Reza hospital of Tabriz (Iran) after having flu-like symptoms. In radiologic assessment, ground glass opacity (GGO) with consolidation was found in upper right lobe. Lopinavir/ritonavir (200mg/50mg) two tablet tow times, Ribavirin 200mg every six hours, and Oseltamivir 75mg tow times were given for the treatment of COVID-19. The medications used for treatment of pneumonia were Meropenem, Ciprofloxacin, Vancomycin. All doses of medications were administrated by adjusted dose assuming the patient is anephric. Also, a few supplements were also given after ATN development including daily Rocaltrol and Nephrovit (as a multivitamin appropriate for patients with renal failure), Folic acid and Calcium carbonate. The patient is still under ventilator with a Fraction of inspired oxygen (FiO2) of 60% and Positive end-expiratory pressure (PEEP) of eight. SpO2 is 94% but the patient's ATN problem has been resolved. We started weaning from mechanical ventilator. The patient is conscious with full awareness to time, person and place. The maternal well-being is achieved and her neonate was discharged.","Respir Med Case Rep","Taghizadieh, Ali","Mikaeili, Haleh","Ahmadi, Majid","Valizadeh, Hamed","32405454"],"abstract":["We reported a 33-year-old female case with novel coronavirus disease 2019 (COVID-19) accompanied by Acute tubular necrosis (ATN). She had a gestational age of 34 weeks. The patient referred to treatment clinic for COVID-19 in Imam Reza hospital of Tabriz (Iran) after having flu-like symptoms. In radiologic assessment, ground glass opacity (GGO) with consolidation was found in upper right lobe. Lopinavir/ritonavir (200mg/50mg) two tablet tow times, Ribavirin 200mg every six hours, and Oseltamivir 75mg tow times were given for the treatment of COVID-19. The medications used for treatment of pneumonia were Meropenem, Ciprofloxacin, Vancomycin. All doses of medications were administrated by adjusted dose assuming the patient is anephric. Also, a few supplements were also given after ATN development including daily Rocaltrol and Nephrovit (as a multivitamin appropriate for patients with renal failure), Folic acid and Calcium carbonate. The patient is still under ventilator with a Fraction of inspired oxygen (FiO2) of 60% and Positive end-expiratory pressure (PEEP) of eight. SpO2 is 94% but the patient's ATN problem has been resolved. We started weaning from mechanical ventilator. The patient is conscious with full awareness to time, person and place. The maternal well-being is achieved and her neonate was discharged."],"journal":"Respir Med Case Rep","authors":["Taghizadieh, Ali","Mikaeili, Haleh","Ahmadi, Majid","Valizadeh, Hamed"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405454","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.rmcr.2020.101090","keywords":["atn","infection","kidney","pregnancy","renal involvement","sars-cov-2"],"locations":["Acute","Tabriz","Iran","Meropenem","Ciprofloxacin","Vancomycin","Nephrovit","Iran"],"countries":["Iran, Islamic Republic of"],"countries_codes":["IRN|Iran, Islamic Republic of"],"e_drugs":["Calcitriol","Ciprofloxacin","Oseltamivir","Ribavirin","Vancomycin","Folic Acid","Calcium Carbonate","Meropenem","lopinavir-ritonavir drug combination"],"topics":["Case Report"],"weight":1,"_version_":1666802845291118592,"score":9.490897,"similar":[{"pmid":32348232,"title":"A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.","text":["A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.","After the initial Wuhan outbreak in the end of December 2019, many new cases were found in other provinces of China and also many other countries over the world, including South Korea, Italy, Iran, Japan, and 68 other countries. We presented a 61-year-old woman with a history of diabetes mellitus was referred to the emergency department of a referral hospital in Tehran, Iran. The patient presented with fever, chills, and myalgia within three days. Laboratory analysis showed increased levels of erythrocyte sedimentation rate (ESR), and mild leukopenia. SARSCoV-2 PCR test -under Iran Ministry of Health and Medical Education (MoH&ME) guidelines - result was positive and the chest X-ray shows bilateral ground glass opacity. O2 saturation was 87% (without O2 therapy). The patient was hospitalized and treated with Oseltamivir 75 mg every 12 hours, Lopinavir/Ritonavir (Kaletra) 400/100 mg every 12 hours and hydroxychloroquine 400 mg stat. The patient last O2 saturation measured was 93% and had no fever in the 10th day of hospitalization. So she has been discharged from hospital and homeisolated according to Iran Ministry of Health protocol.","Infect Disord Drug Targets","Ghiasvand, Fereshteh","Miandoab, Sepideh Zahak","Harandi, Hamid","Golestan, Fereshteh Shahmari","Alinaghi, Seyed Ahmad Seyed","32348232"],"abstract":["After the initial Wuhan outbreak in the end of December 2019, many new cases were found in other provinces of China and also many other countries over the world, including South Korea, Italy, Iran, Japan, and 68 other countries. We presented a 61-year-old woman with a history of diabetes mellitus was referred to the emergency department of a referral hospital in Tehran, Iran. The patient presented with fever, chills, and myalgia within three days. Laboratory analysis showed increased levels of erythrocyte sedimentation rate (ESR), and mild leukopenia. SARSCoV-2 PCR test -under Iran Ministry of Health and Medical Education (MoH&ME) guidelines - result was positive and the chest X-ray shows bilateral ground glass opacity. O2 saturation was 87% (without O2 therapy). The patient was hospitalized and treated with Oseltamivir 75 mg every 12 hours, Lopinavir/Ritonavir (Kaletra) 400/100 mg every 12 hours and hydroxychloroquine 400 mg stat. The patient last O2 saturation measured was 93% and had no fever in the 10th day of hospitalization. So she has been discharged from hospital and homeisolated according to Iran Ministry of Health protocol."],"journal":"Infect Disord Drug Targets","authors":["Ghiasvand, Fereshteh","Miandoab, Sepideh Zahak","Harandi, Hamid","Golestan, Fereshteh Shahmari","Alinaghi, Seyed Ahmad Seyed"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348232","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.2174/1871526520666200429115535","keywords":["covid-19","coronavirus","diabetes mellitus","ground glass opacity","sars-cov-2 pcr test","severe acute respiratory syndrome coronavirus 2"],"locations":["Wuhan","China","South Korea","Italy","Iran","Japan","Tehran","Iran","myalgia","Iran"],"countries":["Korea, Republic of","Japan","China","Iran, Islamic Republic of","Italy"],"countries_codes":["KOR|Korea, Republic of","JPN|Japan","CHN|China","IRN|Iran, Islamic Republic of","ITA|Italy"],"e_drugs":["Hydroxychloroquine","Oseltamivir","lopinavir-ritonavir drug combination"],"topics":["Case Report"],"weight":1,"_version_":1666138495444320256,"score":179.82852},{"pmid":32379699,"title":"Endocrinology in the time of COVID-19: Management of adrenal insufficiency.","text":["Endocrinology in the time of COVID-19: Management of adrenal insufficiency.","We provide guidance on prevention of adrenal crisis during the global COVID-19 crisis, which exposes patients with adrenal insufficiency to an increased risk of acute COVID-19 infection while at the same time restricting access to healthcare due to capacity issues. We highlight the need for education (sick day rules, stringent social distancing rules), equipment (sufficient glucocorticoid supplies, steroid emergency self-injection kit) and empowerment (steroid emergency card, COVID-19 guidelines) to prevent adrenal crises. In patients with adrenal insufficiency developing an acute COVID-19 infection, which frequently presents with continuous high fever, we suggest oral stress dose cover with 20mg hydrocortisone every six hours. We also comment on suggested dosing for patients who usually take modified release hydrocortisone or prednisolone. In patients with clinical insufficiency showing clinical deterioration during an acute COVID-19 infection, we advise immediate (self-)injection of 100mg hydrocortisone intramuscularly, followed by continuous intravenous infusion of 200mg hydrocortisone per 24 hours, or until this can be established, administration of 50mg hydrocortisone every 6 hours.","Eur J Endocrinol","Arlt, Wiebke","Baldeweg, Stephanie E","Pearce, Simon H S","Simpson, Helen L","32379699"],"abstract":["We provide guidance on prevention of adrenal crisis during the global COVID-19 crisis, which exposes patients with adrenal insufficiency to an increased risk of acute COVID-19 infection while at the same time restricting access to healthcare due to capacity issues. We highlight the need for education (sick day rules, stringent social distancing rules), equipment (sufficient glucocorticoid supplies, steroid emergency self-injection kit) and empowerment (steroid emergency card, COVID-19 guidelines) to prevent adrenal crises. In patients with adrenal insufficiency developing an acute COVID-19 infection, which frequently presents with continuous high fever, we suggest oral stress dose cover with 20mg hydrocortisone every six hours. We also comment on suggested dosing for patients who usually take modified release hydrocortisone or prednisolone. In patients with clinical insufficiency showing clinical deterioration during an acute COVID-19 infection, we advise immediate (self-)injection of 100mg hydrocortisone intramuscularly, followed by continuous intravenous infusion of 200mg hydrocortisone per 24 hours, or until this can be established, administration of 50mg hydrocortisone every 6 hours."],"journal":"Eur J Endocrinol","authors":["Arlt, Wiebke","Baldeweg, Stephanie E","Pearce, Simon H S","Simpson, Helen L"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379699","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1530/EJE-20-0361","e_drugs":["Prednisolone","Hydrocortisone","Steroids"],"topics":["Prevention"],"weight":1,"_version_":1666262687575703552,"score":166.0161},{"pmid":32157862,"pmcid":"PMC7161622","title":"CT Manifestations of Novel Coronavirus Pneumonia: A Case Report","text":["CT Manifestations of Novel Coronavirus Pneumonia: A Case Report","Background: Since December 2019, the outbreak of the novel coronavirus has impacted nearly >90,000 people in more than 75 countries. In this case report, we aim to define the chest computed tomography findings of 2019-novel coronavirus associated with pneumonia and its successful resolution after treatment. Case Report: A fifty-year-old female patient, who is a businesswoman, presented with chief complaints of \"fever for one week, diarrhea, anorexia, and asthenia.\" Initially, she was given Tamiflu. The influenza A virus serology was negative. Three days later, levofloxacin was started because the patient's symptoms did not improve. The novel coronavirus nucleic acid test was negative. It was noted that before the onset of the disease, the patient went to Wuhan on a business trip. Despite the given treatment, her body temperature rose to 39.2 degrees C and she was referred to our clinic for further evaluation. Then, chest computed tomography was performed and showed bilateral multifocal ground glass opacities with consolidation which suggested viral pneumonia as a differential diagnosis, and the subsequent 2019-novel coronavirus pneumonia nucleic acid test was positive. Conclusion: Chest computed tomography offers fast and convenient evaluation of patients with suspected 2019-novel coronavirus pneumonia.","Balkan Med J","An, Peng","Song, Ping","Lian, Kai","Wang, Yong","32157862"],"abstract":["Background: Since December 2019, the outbreak of the novel coronavirus has impacted nearly >90,000 people in more than 75 countries. In this case report, we aim to define the chest computed tomography findings of 2019-novel coronavirus associated with pneumonia and its successful resolution after treatment. Case Report: A fifty-year-old female patient, who is a businesswoman, presented with chief complaints of \"fever for one week, diarrhea, anorexia, and asthenia.\" Initially, she was given Tamiflu. The influenza A virus serology was negative. Three days later, levofloxacin was started because the patient's symptoms did not improve. The novel coronavirus nucleic acid test was negative. It was noted that before the onset of the disease, the patient went to Wuhan on a business trip. Despite the given treatment, her body temperature rose to 39.2 degrees C and she was referred to our clinic for further evaluation. Then, chest computed tomography was performed and showed bilateral multifocal ground glass opacities with consolidation which suggested viral pneumonia as a differential diagnosis, and the subsequent 2019-novel coronavirus pneumonia nucleic acid test was positive. Conclusion: Chest computed tomography offers fast and convenient evaluation of patients with suspected 2019-novel coronavirus pneumonia."],"journal":"Balkan Med J","authors":["An, Peng","Song, Ping","Lian, Kai","Wang, Yong"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32157862","source":"PubMed","week":"202011|Mar 09 - Mar 15","doi":"10.4274/balkanmedj.galenos.2020.2020.2.15","keywords":["influenza","novel coronavirus pneumonia","pulmonary complications","computed tomography","diagnosis"],"locations":["diarrhea","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Oseltamivir","Levofloxacin"],"topics":["Case Report"],"weight":1,"_version_":1666138492675031040,"score":164.86641},{"pmid":32222119,"title":"Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.","text":["Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.","The aim is to evaluate pregnant women infected with coronavirus disease 2019 (COVID-19) and provide help for clinical prevention and treatment. All five cases of pregnant women confirmed COVID-19 were collected among patients who admitted to the Maternal and Child Hospital of Hubei Province between January 20 and February 10, 2020. All patients, aging from 25 to 31 years old, had the gestational week from 38th weeks to 41st weeks. All pregnant women did not have an antepartum fever but developed a low-grade fever (37.5-38.5) within 24 hours after delivery. All patients had normal liver and renal function, two patients had elevated plasma levels of the myocardial enzyme. Unusual chest imaging manifestations, featured with ground-grass opacity, were frequently observed in bilateral (three cases) or unilateral lobe (two cases) by computed tomography (CT) scan. All labors smoothly processed, the Apgar scores were 10 points 1 and 5 minutes after delivery, no complications were observed in the newborn. Pregnancy and perinatal outcomes of patients with COVID-19 should receive more attention. It is probable that pregnant women diagnosed with COVID-19 have no fever before delivery. Their primary initial manifestations were merely low-grade postpartum fever or mild respiratory symptoms. Therefore, the protective measures are necessary on admission; the instant CT scan and real-time reverse-transcriptase polymerase-chain-reaction assay should be helpful in early diagnosis and avoid cross-infection on the occasion that patients have fever and other respiratory signs.","J Med Virol","Chen, Siyu","Liao, E","Cao, Dongmei","Gao, Ying","Sun, Guoqiang","Shao, Yong","32222119"],"abstract":["The aim is to evaluate pregnant women infected with coronavirus disease 2019 (COVID-19) and provide help for clinical prevention and treatment. All five cases of pregnant women confirmed COVID-19 were collected among patients who admitted to the Maternal and Child Hospital of Hubei Province between January 20 and February 10, 2020. All patients, aging from 25 to 31 years old, had the gestational week from 38th weeks to 41st weeks. All pregnant women did not have an antepartum fever but developed a low-grade fever (37.5-38.5) within 24 hours after delivery. All patients had normal liver and renal function, two patients had elevated plasma levels of the myocardial enzyme. Unusual chest imaging manifestations, featured with ground-grass opacity, were frequently observed in bilateral (three cases) or unilateral lobe (two cases) by computed tomography (CT) scan. All labors smoothly processed, the Apgar scores were 10 points 1 and 5 minutes after delivery, no complications were observed in the newborn. Pregnancy and perinatal outcomes of patients with COVID-19 should receive more attention. It is probable that pregnant women diagnosed with COVID-19 have no fever before delivery. Their primary initial manifestations were merely low-grade postpartum fever or mild respiratory symptoms. Therefore, the protective measures are necessary on admission; the instant CT scan and real-time reverse-transcriptase polymerase-chain-reaction assay should be helpful in early diagnosis and avoid cross-infection on the occasion that patients have fever and other respiratory signs."],"journal":"J Med Virol","authors":["Chen, Siyu","Liao, E","Cao, Dongmei","Gao, Ying","Sun, Guoqiang","Shao, Yong"],"date":"2020-03-30T11:00:00Z","year":2020,"_id":"32222119","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25789","keywords":["covid-19","clinical manifestations","labor","pregnancy"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666138490454147072,"score":142.96463},{"pmid":32378314,"title":"Early Experience of COVID-19 in Two Heart Transplant Recipients: Case Reports and Review of Treatment Options.","text":["Early Experience of COVID-19 in Two Heart Transplant Recipients: Case Reports and Review of Treatment Options.","The Coronavirus Disease 2019 (COVID-19) pandemic imposes special challenges to immunocompromised transplant patients. Given the paucity of proven data in treating COVID-19, management of these patients is difficult, rapidly evolving, and is mainly based on anecdotal experience. We report 2 cases of heart transplant (HT) recipients with COVID-19. The first is a 59-year-old female with HT in 2012 who presented on March 20, 2020 with fever, hypoxia and ground-glass opacities on chest x-ray. She quickly progressed to acute hypoxic respiratory failure and vasoplegic shock. Despite reduction in immunosuppression, and treatment with tocilizumab, intravenous immunoglobulin, hydroxychloroquine, lopinavir/ritonavir and broad-spectrum antibiotics, she ultimately passed away from multiorgan failure. The second case is a 75-year-old man with HT in 2000 who presented on April 2, 2020 after curbside testing revealed positive COVID-19. Given a milder presentation compared to the first patient, antimetabolite was discontinued and only hydroxychloroquine was started. Due to lack of clinical improvement several days later, tocilizumab, methylprednisolone, and therapeutic anticoagulation were initiated. The patient clinically improved with decreasing oxygen requirements and was discharged home. These two cases highlight the wide range of different presentations of COVID-19 in HT recipients, and the rapidity with which the management of these patients is evolving.","Am J Transplant","Holzhauser, Luise","Lourenco, Laura","Sarswat, Nitasha","Kim, Gene","Chung, Bow","Nguyen, Ann B","32378314"],"abstract":["The Coronavirus Disease 2019 (COVID-19) pandemic imposes special challenges to immunocompromised transplant patients. Given the paucity of proven data in treating COVID-19, management of these patients is difficult, rapidly evolving, and is mainly based on anecdotal experience. We report 2 cases of heart transplant (HT) recipients with COVID-19. The first is a 59-year-old female with HT in 2012 who presented on March 20, 2020 with fever, hypoxia and ground-glass opacities on chest x-ray. She quickly progressed to acute hypoxic respiratory failure and vasoplegic shock. Despite reduction in immunosuppression, and treatment with tocilizumab, intravenous immunoglobulin, hydroxychloroquine, lopinavir/ritonavir and broad-spectrum antibiotics, she ultimately passed away from multiorgan failure. The second case is a 75-year-old man with HT in 2000 who presented on April 2, 2020 after curbside testing revealed positive COVID-19. Given a milder presentation compared to the first patient, antimetabolite was discontinued and only hydroxychloroquine was started. Due to lack of clinical improvement several days later, tocilizumab, methylprednisolone, and therapeutic anticoagulation were initiated. The patient clinically improved with decreasing oxygen requirements and was discharged home. These two cases highlight the wide range of different presentations of COVID-19 in HT recipients, and the rapidity with which the management of these patients is evolving."],"journal":"Am J Transplant","authors":["Holzhauser, Luise","Lourenco, Laura","Sarswat, Nitasha","Kim, Gene","Chung, Bow","Nguyen, Ann B"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32378314","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/ajt.15982","locations":["hypoxia","immunoglobulin","multiorgan"],"e_drugs":["Hydroxychloroquine","tocilizumab","Methylprednisolone","lopinavir-ritonavir drug combination"],"topics":["Case Report"],"weight":1,"_version_":1666262687558926336,"score":142.73828}]}